
Speaker Dr. Barbara Ustaszewski
Affiliation biocrates life sciences
Neurodegenerative diseases and the microbiome
In this webinar, biocrates senior scientist Barbara Ustaszewski shares information about
- Why Alzheimer’s and other neurodegenerative disease can only be understood by looking at the metabolic perspective
- How different disease stages can be characterized by their metabolic signature
- How absolute quantification of biological metabolites empowers the discovery of deeper pathophysiological insights with direct clinical relevance
Related articles
- Transform medicine with metabolomics – Preventive medicine – part 1 of 5
- Citric acid – Key metabolite in energy production, bone health, and disease therapy
- Precision nutrition – Unlocking health through metabolomics
- Oxaloacetic acid (OAA) – Key metabolite in metabolism, disease, and therapeutic innovation
- Introduction to metabolomics in action